期刊文献+

左西孟旦治疗顽固性心力衰竭的临床观察 被引量:1

下载PDF
导出
摘要 目的观察静脉应用左西孟旦治疗顽固性心力衰竭的临床疗效及不良反应。方法选取顽固性心力衰竭患者36例,予常规治疗效果欠佳后给予静脉应用左西孟旦治疗,观察用药后48h生命体征、临床症状(特别是呼吸困难)、心功能等的改善及主要不良反应。结果用药后48h,患者临床状况、呼吸困难程度及心功能均有明显改善;不良反应主要头痛(6%)、低钾血症(8%)和室性早搏(6%)。结论顽固性心力衰竭患者静脉应用左西孟旦后,短期内可取得较好的临床效果,且安全性好。 Objective To observe the clinical effects and side effects of levosimendan on obstinate heart failure. Methods A total of 36 patients of obstinate heart failure were treated with intravenous levosimendan, after poor effects been given regular therapies. Vital signs, clinical situation, dyspnea, heart function and side effects were observed after 48 hours. Results There were obviously improve in the vital signs, clinical situation, dyspnea and heart function. The main side effects were headache, hypokalemia and ventricular premature beats. Conclusion Intravenous levosimendan can obtain good clinical effects and safety in the patients with obstinate heart failure in a short time.
出处 《浙江临床医学》 2013年第2期181-183,共3页 Zhejiang Clinical Medical Journal
关键词 左西孟旦 顽固性心力衰竭 临床观察 Levosimendan Obstinate heart failure Clinical observation
  • 相关文献

参考文献10

  • 1Rognoni A, Lupi A, Lazzero M, et al. Levosimendan:from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov, 2011, 6(1):9-15.
  • 2Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure:the SURVIVE randomized trial. JAM, 2007, 297(17):1883-1891.
  • 3Mathieu S, Craig G. Levosimendan in the treatment of acute heart failure, cardiogenic and septic shock:a critical review . JICS, 2011, 12(1):15-24.
  • 4张宇辉,卿恩明,张健,黄燕,吕蓉,周琼,韦丙奇,安涛,卿平,邹长虹.国产左西孟旦与多巴酚丁胺治疗急性失代偿性心力衰竭患者血液动力学和疗效对比观察[J].中华医学杂志,2012,92(8):555-558. 被引量:61
  • 5Egan JR, Clarke AJ, Wiliams S, et al. Levosimendan for low Cardiac output:a pediatric experience . Intensive Care Med, 2006, 21(3):183-187.
  • 6Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left venrticular failure due to an acute myocardial infarction:a randomized, place bocontrolled, double-blind study(RUSSLAN). Eur Heart J, 2002, 23(18):1422-1432.
  • 7Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure(the LIDO study):a randomized double-blind trial . Lancet, 2002, 360(9328):196-202.
  • 8Kersten J R, Montgomery M W, Pagel P S, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels. Anesth Analg, 2000, 90:5-11.
  • 9Grossini E, Caimmi P P, Molinari C, et al. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig. Cardiovasc Pharmacol, 2005, 46(3):333-342.
  • 10肖军,唐发宽,王龙.低血钾与急性心肌梗死冠脉病变程度及预后的关系[J].医学临床研究,2007,24(1):4-5. 被引量:5

二级参考文献12

  • 1Rognoni A,Lupi A,Lazzero M,et al.Levosimendan:from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov,2011,6:9-15.
  • 2Mebazaa A,Nieminen M,Packer M,et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure:the SURVIVE randomized trial.JAMA,2007,297:1883-1891.
  • 3Krell MJ,Kline EM,Bates ER,et al.Intermittent,ambulatory dobutamine infusion in severe heart failure.Am Heart J,1986,112:787-791.
  • 4Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer,levosimendan in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN).Eur Heart J,2002,23:1422-1432.
  • 5Follath F,Cleland JG,Just H,et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study):a randomised double-blind trial.Lancet,2002,360:196-202.
  • 6Parissis JT, Paraskevaidis I, Bistola V, et al. Effects of levosimendan on right ventricular function in patients with advanced heart failure.Am J Cardiol,2006,98:1489-1492.
  • 7Bergh CH, Andersson B, Dahlstr(o)m U, et al. Intravenous levosimendan vs dobutamine in acute decompensated heart failure patients on beta-blockers. Eur J Heart Failure,2010,12:404-410.
  • 8Nieminen MS, Akkila J, Hasenfuss G. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.J Am Coil Cardiol,2000,36:1903-1912.
  • 9陈灏珠,主译.心脏病学(美)布朗威(BRAUNWALD著[M].第5版.北京:人民卫生出版社,1999.1112-1126.
  • 10Landmark K,Urdal P.Serum magnesium and potassium in acute myocardial infarction:relationship to existing beta-blockade and infarct size[J].Angiology,1993,44(5):347-352.

共引文献64

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部